22.01.2014 23:46:00
|
Quest Diagnostics Incorporated -- Moody's: Quest's announced acquisition of Solstas is credit negative
New York, January 22, 2014 -- Moody's Investors Service commented that the announcement that Quest Diagnostics Incorporated (Quest) has entered into a definitive agreement to acquire Solstas Lab Partners Group (Solstas) for approximately $570 million is a credit negative. However, the announcement has no immediate impact on the company's Baa2 senior unsecured rating. The rating outlook is stable.